![](/img/cover-not-exists.png)
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
Pol, Jonathan G., Acuna, Sergio A., Yadollahi, Beta, Tang, Nan, Stephenson, Kyle B., Atherton, Matthew J., Hanwell, David, El-Warrak, Alexander, Goldstein, Alyssa, Moloo, Badru, Turner, Patricia V., LLanguage:
english
Journal:
OncoImmunology
DOI:
10.1080/2162402x.2018.1512329
Date:
September, 2018
File:
PDF, 5.09 MB
english, 2018